Geri-Michelle McShane - 01 Mar 2026 Form 4 Insider Report for Xylem Inc. (XYL)

Reporting relationship: SVP, CAO
Issuer ticker: XYL
Reported as of: 01 Mar 2026
Net transaction value: +$440,080
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:01:02 UTC
Prior SEC filing: 05 Sep 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mike Nazario, by power of attorney for Geri McShane

Key filing fact

Geri-Michelle McShane filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2026.

Key facts

This page summarizes Geri-Michelle McShane's Form 4 filing for Xylem Inc. (XYL).
9 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:01.

Change

Previous filing in this sequence was filed on 05 Sep 2025.
Current net transaction value: +$440,080.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001769064 Primary reporting owner

McShane Geri-Michelle

Relationship: SVP, CAO
Address: C/O XYLEM INC., 301 WATER STREET SE, WSHINGTON
Signature: /s/ Mike Nazario, by power of attorney for Geri McShane
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XYL transaction

Common Stock

Award

Transaction value: $92,995
Shares: +721
Change %: +24%
Price: $128.98
Shares after: 3,678
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1

XYL transaction

Common Stock

Award

Transaction value: $76,743
Shares: +595
Change %: +16%
Price: $128.98
Shares after: 4,273
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F2

XYL transaction

Common Stock

Award

Transaction value: $52,237
Shares: +405
Change %: +9.5%
Price: $128.98
Shares after: 4,678
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F3

XYL transaction

Common Stock

Award

Transaction value: $63,071
Shares: +489
Change %: +10%
Price: $128.98
Shares after: 5,167
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F4

XYL transaction

Common Stock

Award

Transaction value: $0
Shares: +616
Change %: +12%
Price: $0.000000
Shares after: 5,783
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F5

XYL transaction

Common Stock

Tax liability

Transaction value: $84,353
Shares: -654
Change %: -11%
Price: $128.98
Shares after: 5,129
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F6

XYL transaction

Common Stock

Tax liability

Transaction value: $24,248
Shares: -188
Change %: -3.7%
Price: $128.98
Shares after: 4,941
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F7

XYL transaction

Common Stock

Tax liability

Transaction value: $19,347
Shares: -150
Change %: -3%
Price: $128.98
Shares after: 4,791
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XYL transaction Derivative

Non-Qualified Stock Options (Right to Buy)

Award

Transaction value: $282,982
Shares: +2,194
Change %
Price: $128.98
Shares after: 2,194
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,194
Exercise price: $128.98
Footnotes: F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Reflects the acquisition of 721 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return.

Footnote F2

Reflects the acquisition of 595 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA.

Footnote F3

Reflects the acquisition of 405 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue.

Footnote F4

Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance.

Footnote F5

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029.

Footnote F6

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016).

Footnote F7

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016).

Footnote F8

Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (82) and March 1, 2024 (68) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Footnote F9

Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029.